Fibroscan detection of fatty liver and liver fibrosis in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 723, doi. 10.1177/09612033221094708
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2022 AND VI 31 AND IP 6
Results: 16
1
2
Hematologic manifestations of juvenile systemic lupus erythematosus: An emphasis on anemia.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 730, doi. 10.1177/09612033221093508
- By:
- Publication type:
- Article
3
Comparison of hydroxychloroquine titers measured in frozen/thawed serum and whole blood obtained from lupus patients.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 767, doi. 10.1177/09612033221093506
- By:
- Publication type:
- Article
4
COVID-19 in patients with systemic lupus erythematosus: A systematic review.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 684, doi. 10.1177/09612033221093502
- By:
- Publication type:
- Article
5
Renal outcomes of transient proteinuria in patients with systemic lupus erythematosus treated with corticosteroid therapy alone.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 716, doi. 10.1177/09612033221093500
- By:
- Publication type:
- Article
6
Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
7
CCL21 and IP10 as serum biomarkers for pulmonary involvement in systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 706, doi. 10.1177/09612033221093493
- By:
- Publication type:
- Article
8
Ventricular-arterial coupling in systemic lupus erythematosus women without cardiovascular risk factors.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 765, doi. 10.1177/09612033221093491
- By:
- Publication type:
- Article
9
Comparison of clinical presentation and outcome of childhood-onset and adulthood-onset of systemic lupus erythematosus among Indonesian patients.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 759, doi. 10.1177/09612033221093482
- By:
- Publication type:
- Article
10
Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 744, doi. 10.1177/09612033221091142
- By:
- Publication type:
- Article
11
Efficacy and safety of belimumab therapy in systemic lupus erythematosus: A systematic review and meta-analysis.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 666, doi. 10.1177/09612033221090888
- By:
- Publication type:
- Article
12
The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 697, doi. 10.1177/09612033221090885
- By:
- Publication type:
- Article
13
Interleukin 17A rs2275913 polymorphism is associated with susceptibility to systemic lupus erythematosus: A meta and trial sequential analysis.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 674, doi. 10.1177/09612033221090172
- By:
- Publication type:
- Article
14
Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 659, doi. 10.1177/09612033221090127
- By:
- Publication type:
- Article
15
Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature review.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 650, doi. 10.1177/09612033221088445
- By:
- Publication type:
- Article
16
Organizing pneumonia as a possible pulmonary manifestation of systemic lupus erythematosus: Three cases and a review of literature.
- Published in:
- Lupus, 2022, v. 31, n. 6, p. 737, doi. 10.1177/09612033221088177
- By:
- Publication type:
- Article